Mouse models support this notion as targeted and persistent expression of mutant Kras in the mouse pancreatic epithelium both recapitulates the PanIN to PDA sequence observed in humans, and is required for disease maintenance [1], [2], [3]. Here, KRAS is linked to Patent ductus arteriosus.